AmerisourceBergen (Germany) Performance
| ABG Stock | EUR 218.15 4.95 2.22% |
AmerisourceBergen has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AmerisourceBergen's returns are expected to increase less than the market. However, during the bear market, the loss of holding AmerisourceBergen is expected to be smaller as well. AmerisourceBergen right now shows a risk of 1.37%. Please confirm AmerisourceBergen mean deviation, downside deviation, information ratio, as well as the relationship between the semi deviation and coefficient of variation , to decide if AmerisourceBergen will be following its price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AmerisourceBergen are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, AmerisourceBergen is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.1 B | |
| Total Cashflows From Investing Activities | -368.4 M |
AmerisourceBergen |
AmerisourceBergen Relative Risk vs. Return Landscape
If you would invest 21,185 in AmerisourceBergen on September 13, 2024 and sell it today you would earn a total of 630.00 from holding AmerisourceBergen or generate 2.97% return on investment over 90 days. AmerisourceBergen is currently producing 0.0542% returns and takes up 1.365% volatility of returns over 90 trading days. Put another way, 12% of traded stocks are less volatile than AmerisourceBergen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AmerisourceBergen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AmerisourceBergen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AmerisourceBergen, and traders can use it to determine the average amount a AmerisourceBergen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0397
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ABG | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.37 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average AmerisourceBergen is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AmerisourceBergen by adding it to a well-diversified portfolio.
AmerisourceBergen Fundamentals Growth
AmerisourceBergen Stock prices reflect investors' perceptions of the future prospects and financial health of AmerisourceBergen, and AmerisourceBergen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AmerisourceBergen Stock performance.
| Return On Equity | 0.5 | |||
| Return On Asset | 0.0294 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 33.88 B | |||
| Shares Outstanding | 202.26 M | |||
| Price To Earning | 17.93 X | |||
| Price To Book | 5.05 X | |||
| Price To Sales | 0.13 X | |||
| Revenue | 238.59 B | |||
| EBITDA | 3.09 B | |||
| Cash And Equivalents | 2.88 B | |||
| Cash Per Share | 13.68 X | |||
| Total Debt | 4.63 B | |||
| Debt To Equity | 152.80 % | |||
| Book Value Per Share | (0.88) X | |||
| Cash Flow From Operations | 2.7 B | |||
| Earnings Per Share | 7.77 X | |||
| Total Asset | 56.56 B | |||
About AmerisourceBergen Performance
By analyzing AmerisourceBergen's fundamental ratios, stakeholders can gain valuable insights into AmerisourceBergen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AmerisourceBergen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AmerisourceBergen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania. AMERISOURCEBERGEN operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21000 people.Things to note about AmerisourceBergen performance evaluation
Checking the ongoing alerts about AmerisourceBergen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AmerisourceBergen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AmerisourceBergen has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| AmerisourceBergen has accumulated 4.63 B in total debt with debt to equity ratio (D/E) of 152.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AmerisourceBergen has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AmerisourceBergen until it has trouble settling it off, either with new capital or with free cash flow. So, AmerisourceBergen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AmerisourceBergen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AmerisourceBergen to invest in growth at high rates of return. When we think about AmerisourceBergen's use of debt, we should always consider it together with cash and equity. | |
| Over 78.0% of AmerisourceBergen shares are held by institutions such as insurance companies |
- Analyzing AmerisourceBergen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AmerisourceBergen's stock is overvalued or undervalued compared to its peers.
- Examining AmerisourceBergen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AmerisourceBergen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AmerisourceBergen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AmerisourceBergen's stock. These opinions can provide insight into AmerisourceBergen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AmerisourceBergen Stock analysis
When running AmerisourceBergen's price analysis, check to measure AmerisourceBergen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AmerisourceBergen is operating at the current time. Most of AmerisourceBergen's value examination focuses on studying past and present price action to predict the probability of AmerisourceBergen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AmerisourceBergen's price. Additionally, you may evaluate how the addition of AmerisourceBergen to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |